Stay informed about the trends and policies that impact your commercialisation strategies

To develop and execute successful real world evidence, commercialisation and market access strategies for your product pipeline and on-market products, you need to stay fully informed about ongoing developments in global healthcare systems, relevant pricing and reimbursement trends and policies.

Insights, information, and analysis

Download our latest issue to explore insights, information, and analysis on:

  • Payer trends, and drivers of market access success

  • Pricing policy and regulations in key markets

  • Regulatory agency requirements and policies that govern market approval, and the impact on reimbursement decisions

  • Innovative therapeutic advancements

April 2021 - UK NICE Health Technology Assessment proposed changes

In a statement on February 2021, the UK’s National Institute for Health and Care Excellence (NICE) launched a public consultation on proposals for changes to the processes it uses to develop its guidance on medicines, medical devices, diagnostics and digital health technologies.

Download the briefing for an outline of the changes proposed by NICE. The consultation document for NICE health technology assessment (HTA) process changes is open for comment until 15th April 2021.

Read the briefing